HLS Therapeutics Inc. HLTRF 价格预测与展望

Q: 技术分析指标如何适用于 HLTRF？

根据技术分析，HLS Therapeutics Inc. 的综合信号为 Neutral。HLS Therapeutics Inc. 有 3 个买入信号，1 个中性信号和 3 个卖出信号。

Q: HLTRF 的斐波那契回调水平是多少？

HLS Therapeutics Inc. 的斐波那契回调水平是 在 38.2% 和 50% 之间。

Q: HLS Therapeutics Inc. 的 RSI 是多少？

HLS Therapeutics Inc. 的 RSI 目前为 31.31，表明处于 中立 状态

Q: HLS Therapeutics Inc. 接下来 12 个月的价格是多少？

HLS Therapeutics Inc. HLTRF 接下来 12 个月的价格预计为 $4.82。

Q: HLS Therapeutics Inc. 预计会涨到多高？

据华尔街分析师称，HLS Therapeutics Inc. 预计将达到 $6.98 的高预测值。

主页

股票

HLTRF

预测

HLTRF 股票价格预测

HLS Therapeutics Inc.

$3.36

截至今日：Jan 28, 14:46:41 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

$3.36

开盘价

$3.45

当日区间

$3.36 - $3.45

52周范围

$2.73 - $4.02

交易量

400

平均成交量

每股收益（TTM）

-0.45

股息收益率

市值

$105.1M

什么是 HLS Therapeutics Inc.？

HLS Therapeutics, Inc. engages in commercializing pharmaceutical products. The company is headquartered in Etobicoke, Ontario and currently employs 92 full-time employees. The company is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Vascepa capsules are a single-molecule prescription product for the treatment of cardiovascular disease.

功能特性

交易策略

资源

市场

Utilizing our sophisticated predictive model, we anticipate notable price fluctuations for HLTRF in the upcoming periods. Looking toward the future, our 2026 projection indicates an average price target of $4.82. The lowest target is $2.82 and the highest is $6.98. Empower your investment choices with our cutting-edge, data-driven analysis!

HLTRF 股价预测摘要

HLTRF的顶级分析师评级

基于 9 位分析师对 HLTRF 的股票评级，更新于 Sep 01, 2025

Buy

Strong buy

Buy

Hold

Sell

Strong sell

Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for HLTRF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: HLTRF is a Buy candidate.

HLTRF stock price ended at $3.36 on 星期四, after dropping 2.04%

On the latest trading day Jan 08, 2026, the stock price of HLTRF fell by 2.04%, dropping from $3.36 to $3.36. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $3.36 and a high of $3.36. On the latest trading day, the trading volume for HLTRF rose by -- shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 100 shares were traded, with a market value of approximately $105.0M.

HLTRF 技术面信号

技术面信号摘要

购买信号 3

中性信号 1

卖出信号 3

Strong Sell

Sell

Neutral

Buy

Strong Buy

HLTRF目前显示3个买入信号和3个卖出信号。该股票自12:00 AM以来一直处于下降趋势状态，在此期间价格总变动为-2.33%。总体而言，技术指标显示中期前景为Neutral。

HLTRF 的看涨/看跌信号

我们的算法通过分析移动平均线、RSI、MACD 和成交量等关键指标，为 HLTRF 生成看涨和看跌信号。这些见解可助您做出明智的投资决策。

后续问题

技术分析指标如何适用于 HLTRF？



HLTRF 的斐波那契回调水平是多少？



HLS Therapeutics Inc. 的 RSI 是多少？



HLS Therapeutics Inc. 接下来 12 个月的价格是多少？



HLS Therapeutics Inc. 预计会涨到多高？



HLS Therapeutics Inc.（HLTRF）价格

HLTRF 股价走势图